Filed: 11/14/2022ACC: 0001567619-22-020127
📋 What this filing means
72 INVESTMENT HOLDINGS, LLC filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $126.2K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$126.2K
Total AUM (reported)
4.17M
Total Shares
Allocation by class
COM$124.3K98.5%
COMMON STOCK$1.9K1.5%
Portfolio Concentration
Top 3$122.1K96.7%
4–10$4.2K3.3%
Top 3 weight
96.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 4.17M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
4.17M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other5
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings5
Rows:
PROMETHEUS BIOSCIENCES INC
DFNDShares1.85M
TypeSH
Market value$109.1K
86.39%
Sole
0.00
Shared
1.85M
None
0.00
ENTRADA THERAPEUTICS INC
DFNDShares509.02K
TypeSH
Market value$8.0K
6.35%
Sole
0.00
Shared
509.02K
None
0.00
CARIBOU BIOSCIENCES INC
DFNDShares474.07K
TypeSH
Market value$5.0K
3.96%
Sole
0.00
Shared
474.07K
None
0.00
PRAXIS PRECISION MEDICINES I
DFNDShares989K
TypeSH
Market value$2.2K
1.78%
Sole
0.00
Shared
989K
None
0.00
OMEGA THERAPEUTICS INC
DFNDShares352.94K
TypeSH
Market value$1.9K
1.52%
Sole
0.00
Shared
352.94K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PROMETHEUS BIOSCIENCES INCDFND | COM | 1.85M | SH | $109.1K 86.39% | 0.00 | 1.85M | 0.00 |
ENTRADA THERAPEUTICS INCDFND | COM | 509.02K | SH | $8.0K 6.35% | 0.00 | 509.02K | 0.00 |
CARIBOU BIOSCIENCES INCDFND | COM | 474.07K | SH | $5.0K 3.96% | 0.00 | 474.07K | 0.00 |
PRAXIS PRECISION MEDICINES IDFND | COM | 989K | SH | $2.2K 1.78% | 0.00 | 989K | 0.00 |
OMEGA THERAPEUTICS INCDFND | COMMON STOCK | 352.94K | SH | $1.9K 1.52% | 0.00 | 352.94K | 0.00 |